Sun Pharma’s European partner withdraws application for skin cancer treatment therapy

India’s largest drugmaker, Sun Pharmaceutical Industries Ltd., announced on Wednesday that its European biotech partner Philogen has voluntarily withdrawn the marketing authorisation application (MAA) for its investigational therapy Nidlegy from…

Sun Pharma Stock: Is the 28.72% Potential Upside Realistic?

Sun Pharma is a top-ranked Indian pharmaceutical firm. The company’s stock has been continuously in the news lately for walking on the thin line of marketplace volatility, governmental regulations, and…